Total Visits

Views
Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A81

Select a period of time:

Views

Views
November 20250
December 20251
January 20261
February 20260
March 20264
April 202610
May 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Tunisia2
Argentina1
Canada1
China1
Colombia1
Germany1
France1
United Kingdom1
Nigeria1
 

Top cities views

Views
Los Angeles2
Antalya1
Hammamet1
Kolda1
Lagos1
Newark1
San Miguel de Tucumán1
Tozeur1
Valencia1
Villavicencio1